img

Global Point-of-care Cancer Screening Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Point-of-care Cancer Screening Market Research Report 2024

According to MRAResearch’s new survey, global Point-of-care Cancer Screening market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Point-of-care Cancer Screening market research.
Key companies engaged in the Point-of-care Cancer Screening industry include Hologic Corporation, Abbott Laboratories, Qiagen N.V., F Hoffmann-La Roche, BD, Quest Diagnostics, OncoHealth Corp, Danaher and NOVIGENIX SA, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Point-of-care Cancer Screening were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Point-of-care Cancer Screening market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Point-of-care Cancer Screening market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Hologic Corporation
Abbott Laboratories
Qiagen N.V.
F Hoffmann-La Roche
BD
Quest Diagnostics
OncoHealth Corp
Danaher
NOVIGENIX SA
Quidel Corporation
Segment by Type
Genetic Screening
Image Screening
Others

Segment by Application


Hospital
Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Point-of-care Cancer Screening report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Point-of-care Cancer Screening Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Genetic Screening
1.2.3 Image Screening
1.2.4 Others
1.3 Market by Application
1.3.1 Global Point-of-care Cancer Screening Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Point-of-care Cancer Screening Market Perspective (2018-2033)
2.2 Point-of-care Cancer Screening Growth Trends by Region
2.2.1 Global Point-of-care Cancer Screening Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Point-of-care Cancer Screening Historic Market Size by Region (2018-2023)
2.2.3 Point-of-care Cancer Screening Forecasted Market Size by Region (2024-2033)
2.3 Point-of-care Cancer Screening Market Dynamics
2.3.1 Point-of-care Cancer Screening Industry Trends
2.3.2 Point-of-care Cancer Screening Market Drivers
2.3.3 Point-of-care Cancer Screening Market Challenges
2.3.4 Point-of-care Cancer Screening Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Point-of-care Cancer Screening Players by Revenue
3.1.1 Global Top Point-of-care Cancer Screening Players by Revenue (2018-2023)
3.1.2 Global Point-of-care Cancer Screening Revenue Market Share by Players (2018-2023)
3.2 Global Point-of-care Cancer Screening Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Point-of-care Cancer Screening Revenue
3.4 Global Point-of-care Cancer Screening Market Concentration Ratio
3.4.1 Global Point-of-care Cancer Screening Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Point-of-care Cancer Screening Revenue in 2022
3.5 Point-of-care Cancer Screening Key Players Head office and Area Served
3.6 Key Players Point-of-care Cancer Screening Product Solution and Service
3.7 Date of Enter into Point-of-care Cancer Screening Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Point-of-care Cancer Screening Breakdown Data by Type
4.1 Global Point-of-care Cancer Screening Historic Market Size by Type (2018-2023)
4.2 Global Point-of-care Cancer Screening Forecasted Market Size by Type (2024-2033)
5 Point-of-care Cancer Screening Breakdown Data by Application
5.1 Global Point-of-care Cancer Screening Historic Market Size by Application (2018-2023)
5.2 Global Point-of-care Cancer Screening Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Point-of-care Cancer Screening Market Size (2018-2033)
6.2 North America Point-of-care Cancer Screening Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Point-of-care Cancer Screening Market Size by Country (2018-2023)
6.4 North America Point-of-care Cancer Screening Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Point-of-care Cancer Screening Market Size (2018-2033)
7.2 Europe Point-of-care Cancer Screening Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Point-of-care Cancer Screening Market Size by Country (2018-2023)
7.4 Europe Point-of-care Cancer Screening Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Point-of-care Cancer Screening Market Size (2018-2033)
8.2 Asia-Pacific Point-of-care Cancer Screening Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Point-of-care Cancer Screening Market Size by Region (2018-2023)
8.4 Asia-Pacific Point-of-care Cancer Screening Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Point-of-care Cancer Screening Market Size (2018-2033)
9.2 Latin America Point-of-care Cancer Screening Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Point-of-care Cancer Screening Market Size by Country (2018-2023)
9.4 Latin America Point-of-care Cancer Screening Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Point-of-care Cancer Screening Market Size (2018-2033)
10.2 Middle East & Africa Point-of-care Cancer Screening Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Point-of-care Cancer Screening Market Size by Country (2018-2023)
10.4 Middle East & Africa Point-of-care Cancer Screening Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Hologic Corporation
11.1.1 Hologic Corporation Company Detail
11.1.2 Hologic Corporation Business Overview
11.1.3 Hologic Corporation Point-of-care Cancer Screening Introduction
11.1.4 Hologic Corporation Revenue in Point-of-care Cancer Screening Business (2018-2023)
11.1.5 Hologic Corporation Recent Development
11.2 Abbott Laboratories
11.2.1 Abbott Laboratories Company Detail
11.2.2 Abbott Laboratories Business Overview
11.2.3 Abbott Laboratories Point-of-care Cancer Screening Introduction
11.2.4 Abbott Laboratories Revenue in Point-of-care Cancer Screening Business (2018-2023)
11.2.5 Abbott Laboratories Recent Development
11.3 Qiagen N.V.
11.3.1 Qiagen N.V. Company Detail
11.3.2 Qiagen N.V. Business Overview
11.3.3 Qiagen N.V. Point-of-care Cancer Screening Introduction
11.3.4 Qiagen N.V. Revenue in Point-of-care Cancer Screening Business (2018-2023)
11.3.5 Qiagen N.V. Recent Development
11.4 F Hoffmann-La Roche
11.4.1 F Hoffmann-La Roche Company Detail
11.4.2 F Hoffmann-La Roche Business Overview
11.4.3 F Hoffmann-La Roche Point-of-care Cancer Screening Introduction
11.4.4 F Hoffmann-La Roche Revenue in Point-of-care Cancer Screening Business (2018-2023)
11.4.5 F Hoffmann-La Roche Recent Development
11.5 BD
11.5.1 BD Company Detail
11.5.2 BD Business Overview
11.5.3 BD Point-of-care Cancer Screening Introduction
11.5.4 BD Revenue in Point-of-care Cancer Screening Business (2018-2023)
11.5.5 BD Recent Development
11.6 Quest Diagnostics
11.6.1 Quest Diagnostics Company Detail
11.6.2 Quest Diagnostics Business Overview
11.6.3 Quest Diagnostics Point-of-care Cancer Screening Introduction
11.6.4 Quest Diagnostics Revenue in Point-of-care Cancer Screening Business (2018-2023)
11.6.5 Quest Diagnostics Recent Development
11.7 OncoHealth Corp
11.7.1 OncoHealth Corp Company Detail
11.7.2 OncoHealth Corp Business Overview
11.7.3 OncoHealth Corp Point-of-care Cancer Screening Introduction
11.7.4 OncoHealth Corp Revenue in Point-of-care Cancer Screening Business (2018-2023)
11.7.5 OncoHealth Corp Recent Development
11.8 Danaher
11.8.1 Danaher Company Detail
11.8.2 Danaher Business Overview
11.8.3 Danaher Point-of-care Cancer Screening Introduction
11.8.4 Danaher Revenue in Point-of-care Cancer Screening Business (2018-2023)
11.8.5 Danaher Recent Development
11.9 NOVIGENIX SA
11.9.1 NOVIGENIX SA Company Detail
11.9.2 NOVIGENIX SA Business Overview
11.9.3 NOVIGENIX SA Point-of-care Cancer Screening Introduction
11.9.4 NOVIGENIX SA Revenue in Point-of-care Cancer Screening Business (2018-2023)
11.9.5 NOVIGENIX SA Recent Development
11.10 Quidel Corporation
11.10.1 Quidel Corporation Company Detail
11.10.2 Quidel Corporation Business Overview
11.10.3 Quidel Corporation Point-of-care Cancer Screening Introduction
11.10.4 Quidel Corporation Revenue in Point-of-care Cancer Screening Business (2018-2023)
11.10.5 Quidel Corporation Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Point-of-care Cancer Screening Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Genetic Screening
Table 3. Key Players of Image Screening
Table 4. Key Players of Others
Table 5. Global Point-of-care Cancer Screening Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Point-of-care Cancer Screening Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Point-of-care Cancer Screening Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Point-of-care Cancer Screening Market Share by Region (2018-2023)
Table 9. Global Point-of-care Cancer Screening Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 10. Global Point-of-care Cancer Screening Market Share by Region (2024-2033)
Table 11. Point-of-care Cancer Screening Market Trends
Table 12. Point-of-care Cancer Screening Market Drivers
Table 13. Point-of-care Cancer Screening Market Challenges
Table 14. Point-of-care Cancer Screening Market Restraints
Table 15. Global Point-of-care Cancer Screening Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Point-of-care Cancer Screening Market Share by Players (2018-2023)
Table 17. Global Top Point-of-care Cancer Screening Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Point-of-care Cancer Screening as of 2022)
Table 18. Ranking of Global Top Point-of-care Cancer Screening Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Point-of-care Cancer Screening Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Point-of-care Cancer Screening Product Solution and Service
Table 22. Date of Enter into Point-of-care Cancer Screening Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Point-of-care Cancer Screening Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Point-of-care Cancer Screening Revenue Market Share by Type (2018-2023)
Table 26. Global Point-of-care Cancer Screening Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 27. Global Point-of-care Cancer Screening Revenue Market Share by Type (2024-2033)
Table 28. Global Point-of-care Cancer Screening Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Point-of-care Cancer Screening Revenue Market Share by Application (2018-2023)
Table 30. Global Point-of-care Cancer Screening Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 31. Global Point-of-care Cancer Screening Revenue Market Share by Application (2024-2033)
Table 32. North America Point-of-care Cancer Screening Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 33. North America Point-of-care Cancer Screening Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Point-of-care Cancer Screening Market Size by Country (2024-2033) & (US$ Million)
Table 35. Europe Point-of-care Cancer Screening Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. Europe Point-of-care Cancer Screening Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Point-of-care Cancer Screening Market Size by Country (2024-2033) & (US$ Million)
Table 38. Asia-Pacific Point-of-care Cancer Screening Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 39. Asia-Pacific Point-of-care Cancer Screening Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Point-of-care Cancer Screening Market Size by Region (2024-2033) & (US$ Million)
Table 41. Latin America Point-of-care Cancer Screening Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 42. Latin America Point-of-care Cancer Screening Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Point-of-care Cancer Screening Market Size by Country (2024-2033) & (US$ Million)
Table 44. Middle East & Africa Point-of-care Cancer Screening Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 45. Middle East & Africa Point-of-care Cancer Screening Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Point-of-care Cancer Screening Market Size by Country (2024-2033) & (US$ Million)
Table 47. Hologic Corporation Company Detail
Table 48. Hologic Corporation Business Overview
Table 49. Hologic Corporation Point-of-care Cancer Screening Product
Table 50. Hologic Corporation Revenue in Point-of-care Cancer Screening Business (2018-2023) & (US$ Million)
Table 51. Hologic Corporation Recent Development
Table 52. Abbott Laboratories Company Detail
Table 53. Abbott Laboratories Business Overview
Table 54. Abbott Laboratories Point-of-care Cancer Screening Product
Table 55. Abbott Laboratories Revenue in Point-of-care Cancer Screening Business (2018-2023) & (US$ Million)
Table 56. Abbott Laboratories Recent Development
Table 57. Qiagen N.V. Company Detail
Table 58. Qiagen N.V. Business Overview
Table 59. Qiagen N.V. Point-of-care Cancer Screening Product
Table 60. Qiagen N.V. Revenue in Point-of-care Cancer Screening Business (2018-2023) & (US$ Million)
Table 61. Qiagen N.V. Recent Development
Table 62. F Hoffmann-La Roche Company Detail
Table 63. F Hoffmann-La Roche Business Overview
Table 64. F Hoffmann-La Roche Point-of-care Cancer Screening Product
Table 65. F Hoffmann-La Roche Revenue in Point-of-care Cancer Screening Business (2018-2023) & (US$ Million)
Table 66. F Hoffmann-La Roche Recent Development
Table 67. BD Company Detail
Table 68. BD Business Overview
Table 69. BD Point-of-care Cancer Screening Product
Table 70. BD Revenue in Point-of-care Cancer Screening Business (2018-2023) & (US$ Million)
Table 71. BD Recent Development
Table 72. Quest Diagnostics Company Detail
Table 73. Quest Diagnostics Business Overview
Table 74. Quest Diagnostics Point-of-care Cancer Screening Product
Table 75. Quest Diagnostics Revenue in Point-of-care Cancer Screening Business (2018-2023) & (US$ Million)
Table 76. Quest Diagnostics Recent Development
Table 77. OncoHealth Corp Company Detail
Table 78. OncoHealth Corp Business Overview
Table 79. OncoHealth Corp Point-of-care Cancer Screening Product
Table 80. OncoHealth Corp Revenue in Point-of-care Cancer Screening Business (2018-2023) & (US$ Million)
Table 81. OncoHealth Corp Recent Development
Table 82. Danaher Company Detail
Table 83. Danaher Business Overview
Table 84. Danaher Point-of-care Cancer Screening Product
Table 85. Danaher Revenue in Point-of-care Cancer Screening Business (2018-2023) & (US$ Million)
Table 86. Danaher Recent Development
Table 87. NOVIGENIX SA Company Detail
Table 88. NOVIGENIX SA Business Overview
Table 89. NOVIGENIX SA Point-of-care Cancer Screening Product
Table 90. NOVIGENIX SA Revenue in Point-of-care Cancer Screening Business (2018-2023) & (US$ Million)
Table 91. NOVIGENIX SA Recent Development
Table 92. Quidel Corporation Company Detail
Table 93. Quidel Corporation Business Overview
Table 94. Quidel Corporation Point-of-care Cancer Screening Product
Table 95. Quidel Corporation Revenue in Point-of-care Cancer Screening Business (2018-2023) & (US$ Million)
Table 96. Quidel Corporation Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Point-of-care Cancer Screening Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Point-of-care Cancer Screening Market Share by Type: 2022 VS 2033
Figure 3. Genetic Screening Features
Figure 4. Image Screening Features
Figure 5. Others Features
Figure 6. Global Point-of-care Cancer Screening Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 7. Global Point-of-care Cancer Screening Market Share by Application: 2022 VS 2033
Figure 8. Hospital Case Studies
Figure 9. Clinic Case Studies
Figure 10. Others Case Studies
Figure 11. Point-of-care Cancer Screening Report Years Considered
Figure 12. Global Point-of-care Cancer Screening Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 13. Global Point-of-care Cancer Screening Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 14. Global Point-of-care Cancer Screening Market Share by Region: 2022 VS 2033
Figure 15. Global Point-of-care Cancer Screening Market Share by Players in 2022
Figure 16. Global Top Point-of-care Cancer Screening Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Point-of-care Cancer Screening as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Point-of-care Cancer Screening Revenue in 2022
Figure 18. North America Point-of-care Cancer Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. North America Point-of-care Cancer Screening Market Share by Country (2018-2033)
Figure 20. United States Point-of-care Cancer Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Canada Point-of-care Cancer Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Point-of-care Cancer Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Point-of-care Cancer Screening Market Share by Country (2018-2033)
Figure 24. Germany Point-of-care Cancer Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. France Point-of-care Cancer Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. U.K. Point-of-care Cancer Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Italy Point-of-care Cancer Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Russia Point-of-care Cancer Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Nordic Countries Point-of-care Cancer Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Point-of-care Cancer Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Point-of-care Cancer Screening Market Share by Region (2018-2033)
Figure 32. China Point-of-care Cancer Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Japan Point-of-care Cancer Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. South Korea Point-of-care Cancer Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Southeast Asia Point-of-care Cancer Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. India Point-of-care Cancer Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Australia Point-of-care Cancer Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Point-of-care Cancer Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Point-of-care Cancer Screening Market Share by Country (2018-2033)
Figure 40. Mexico Point-of-care Cancer Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Brazil Point-of-care Cancer Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Point-of-care Cancer Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Point-of-care Cancer Screening Market Share by Country (2018-2033)
Figure 44. Turkey Point-of-care Cancer Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Saudi Arabia Point-of-care Cancer Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Hologic Corporation Revenue Growth Rate in Point-of-care Cancer Screening Business (2018-2023)
Figure 47. Abbott Laboratories Revenue Growth Rate in Point-of-care Cancer Screening Business (2018-2023)
Figure 48. Qiagen N.V. Revenue Growth Rate in Point-of-care Cancer Screening Business (2018-2023)
Figure 49. F Hoffmann-La Roche Revenue Growth Rate in Point-of-care Cancer Screening Business (2018-2023)
Figure 50. BD Revenue Growth Rate in Point-of-care Cancer Screening Business (2018-2023)
Figure 51. Quest Diagnostics Revenue Growth Rate in Point-of-care Cancer Screening Business (2018-2023)
Figure 52. OncoHealth Corp Revenue Growth Rate in Point-of-care Cancer Screening Business (2018-2023)
Figure 53. Danaher Revenue Growth Rate in Point-of-care Cancer Screening Business (2018-2023)
Figure 54. NOVIGENIX SA Revenue Growth Rate in Point-of-care Cancer Screening Business (2018-2023)
Figure 55. Quidel Corporation Revenue Growth Rate in Point-of-care Cancer Screening Business (2018-2023)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed